It began with a simple discrepancy. JIMON GROUP’s official website says the company was founded in 1993. China’s state corporate registry says the legal entity was registered on 11 May 2004. An eleven-year gap is the kind of discrepancy on which many exposés are built. I began with scepticism too. But the deeper I went into the documents, the clearer it became that this was not just another project with a polished website. The story was much more interesting.
This video is the result of a large independent investigation. I examined government registries and patent databases, industry directories from twenty years ago, university archives and court databases, and the company’s digital footprint across three decades. I took JIMON GROUP apart piece by piece—not through presentations, but through documents.
What you will learn from this video
The video is built as nine successive research steps, with each one growing out of the previous one.
The mystery of two dates. Why the discrepancy between 1993 and 2004 is not a deception but, on the contrary, the first sign of a genuine industrial business that grew organically rather than being assembled for publicity.
A city built around medicine. JIMON’s headquarters is not in Beijing or Shanghai, but in Anguo—a city whose official designation is “China’s millennial capital of medicinal raw materials.” What does that mean in practice, and why did JIMON not simply arrive in Anguo, but grow out of the environment there?
Four brands and a century-old heritage. Baoding Traditional Chinese Medicine, Anyao Group, Yubentang Holding Group and Yishoutang are four pharmaceutical brands, each more than a century old. Why, in traditional medicine, an old brand is not merely a logo, but can also represent proprietary formulations, technologies that cannot be fully described in a patent, and people who pass their skills down from one generation to the next.
The “one centre + six bases” system. A full production cycle that 90% of competitors lack: proprietary seeds, the company’s own fields, drying, extraction, manufacturing, quality control and logistics—with no intermediaries. An entry in a 2004 presentation about the first organic cultivation base proves that this strategy was laid out twenty years ago.
Science in practice. National High-Tech Enterprise status in China (2024), an in-house research institute, more than 90 specialists in the research team, partnerships with Tianjin University of Traditional Chinese Medicine and the Chinese Academy of Sciences, patents, and a database of more than 16,000 verified formulas.
The product portfolio. More than 300 active registrations of medicinal products in the national register—a volume that would typically be enough for three or four independent pharmaceutical companies—and 11 exclusive medicines whose formulas are assigned exclusively to JIMON GROUP.
Documents that cannot simply be bought. A timeline of government-recognised statuses from 2018 to 2025, from provincial technology centre to the Hebei Government Quality Award, and why this exact sequence of awards cannot be fabricated.
International presence. An assessment of exports without embellishment: Singapore, Malaysia, South Korea, Canada, Germany, France and Slovakia, along with four levels of global presence that I use to assess any company claiming to “operate worldwide.”
The OSINT audit and final verdict. A full independent review of open sources worldwide: registries, court databases, university archives and a digital footprint spanning thirty years. I was not looking for confirmation; I was looking for contradictions. What did I find, and what score did I assign on a ten-point scale? Watch the final part of the video.
Why this video is worth watching in full
I have deliberately not revealed the investigation’s main conclusion here. Not because there is no conclusion, but because the value of the video lies not in a single answer paragraph, but in the path taken to reach it. The most striking part of the story is that each new layer of evidence did not expose the company—as happens in nine out of ten investigations of this kind. Instead, every document I found only deepened and strengthened the foundations beneath it.
If you have ever wondered what JIMON GROUP really is—a genuine industrial holding or a well-constructed imitation of a large business—this video settles the question through documentary evidence. No advertising, no blind faith and no corporate clichés.
Watch the video below. The investigation will continue, and its next part focuses on what we have deliberately not discussed here: the products themselves and the results people experience.
Research keys
Browse the topic archives for this article.